Pattern hair loss can occur in both men and women, the underlying molecular mechanisms have been continuously studied recent years. Male androgenetic alopecia (M-AGA), also termed male pattern loss, is most common type of men. M-AGA considered an androgen-dependent trait with a background genetic predisposition. The interplay between non-genetic factors leads to phenotype follicular miniaturiza...

<p><strong>Background:</strong> Minoxidil and finasteride are most common drugs used in androgenetic alopecia. The objective of the study was to know efficacy topical minoxidil solution with without finasteride.</p><p><strong>Methods:</strong> In total about 30 subjects, aged 18-45 years, who came for outpatient consultation male pattern alopecia were r...

clinical practice guidelines are the most important and valid guidelines for treatment of diseases, and are developed through experts consensus on a subject, considering the highest available evidence (systematic reviews, meta-analyses, and randomized controlled trials). we briefly review the latest evidence-based guidelines for the treatment of two common diseases of acne (provided by european...

Minoxidil is a piperidine-pyrimidine derivative and potent vasodilator approved orally for severe hypertension topically androgenetic alopecia (AGA).[1][1] The minimum plasma threshold induction of hair growth an order magnitude below the required any hemodynamic

The treatment of hair loss diseases is sometimes difficult because of insufficient efficacy and limited options. However, recent advances in understanding of the pathophysiology and development of new remedies have improved the treatment of refractory hair loss conditions. In this article, an update on the management of hair loss diseases is provided, especially focusing on recently reported th...